首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Preparation, in vitro and in vivo studies of liver-targeting Dexamethasone acetate nanostructured lipid carrier system
【24h】

Preparation, in vitro and in vivo studies of liver-targeting Dexamethasone acetate nanostructured lipid carrier system

机译:肝脏靶向乙酸乙酸碱性脂质载体系统的制备,体外和体内研究

获取原文

摘要

A novel nanostructured lipid carrier (NLC) for liver-targeting delivery of dexamethasone acetate (DXMA) was prepared by film dispersion- ultrasonication method. DXMA-NLC displayed liver- targeting and sustained release properties in vivo and exhibited anti-inflammatory effect on carbon tetrachloride induced mice.
机译:通过薄膜分散超声法制备了用于肝靶向乙酸乙酸乙酸乙酸乙酸乙酸甲酸酯(DXMA)的新型纳米结构脂质载体(NLC)。 DXMA-NLC在体内显示肝脏靶向和持续的释放性质,并对碳四氯化碳诱导小鼠表现出抗炎作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号